Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.113667
Revised: September 21, 2025
Accepted: December 4, 2025
Published online: February 18, 2026
Processing time: 156 Days and 1.1 Hours
With the advent of recent point of care testing to evaluate for prosthetic joint infection (PJI) such as alpha-defensin and calprotectin, the diagnosis of PJI has reached a new paramount. The most widely accepted diagnostic criteria in the literature at this time is the international consensus meeting (ICM) score by Parvizi et al in 2018. One of the proposed limitations of the ICM criteria is de
To determine if the “true leukocytosis” formula for prosthetic joint aspirations is useful in determining PJIs.
Of 158 cases with International Classification of Diseases, 10th revision diagnoses of total knee arthroplasty PJIs from 2020-2021 from a single health system were reviewed and preoperative ICM scores were calculated. Inclusion criteria in
Of 81 cases met the inclusion criteria and had preoperative ICM scores calculated. Of the 81 cases that met inclusion criteria, no cases were found to have different preoperative ICM scores after applying the correction formula for “true leukocytosis” proposed by Ghanem et al in 2008.
Given the lack of variance in ICM score following the proposed correction formula, it appears that the proposed “true leukocytosis” formula is not a useful adjuvant in treatment decision making.
Core Tip: In this study we examine the usefulness of applying a correction formula for synovial fluid aspirations that contain red blood cells when determining prosthetic joint infections (PJI) using the international consensus meeting criteria. We compare the international consensus meeting criteria for PJI score both prior to and after applying the correction formula to evaluate if there would be any change to diagnosis in patients with concern for PJI.
- Citation: Sweeney BM, Sadhwani S, Edwards T, Kelly M. Value of “true” leukocytosis formula in determining total knee arthroplasty prosthetic joint infection in the community hospital setting. World J Orthop 2026; 17(2): 113667
- URL: https://www.wjgnet.com/2218-5836/full/v17/i2/113667.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i2.113667
Prosthetic joint infection (PJI) is a devastating complication following total knee arthroplasty (TKA). While the overall rate of PJI in TKA appear to have remained consistent over the past three decades[1], the incidence of primary TKA has continued to rise and is projected to increase to a total of 3.48 million procedures a year in the United States by 2030 with other estimates suggesting that the incidence of TKA could be even higher by 2040[2-5]. With this increase in primary TKA there will also come an increase in incidence of revision TKA which will place a large burden on the healthcare system from both a clinical and economic standpoint. Over a 10-year period, Livshetz et al[3] projected that the cost of revision total knee will create up to 4.1 billion United States dollars in hospital charges[6]. Given that infection is the most common cause for revision TKA, accounting for up to 25% of revisions, we can therefore also expect an increase in PJI with the expected increase in revisions[7].
While this complication is well described in the literature there remain several identifiable problems in both the diagnoses and treatment of PJI. Many criteria have been suggested and subsequently revised for the diagnoses of PJI: Musculoskeletal Infection Society criteria (2011), international consensus meeting (ICM) criteria[8] and European Bone and Joint Infection Society criteria (2021)[8-11]. The criteria with the highest sensitivity, specificity, and internal validation are the 2018 criteria proposed by the ICM[8]. Certain issues remain despite the clear guidelines listed in the ICM criteria, specifically in the community setting[12].
The ICM criteria currently utilizes major and minor criteria for diagnoses. The major criteria being a draining sinus track that probes down to prosthesis or a positive culture on aspiration. If either of the major criteria are met, the prosthetic joint is assumed to be infected. The minor criteria requires that the affected joint be aspirated, and the fluid sent for analysis of total nucleated cell count (> 3000 = 3 points), neutrophil percentage (> 80% = 2 points) , presence of alpha-defensin (3-points), leukocyte esterase (3-points), and C-reactive protein (CRP, 3-points); it also calls for serum erythrocyte sedimentation rate (> 30 mm/hour = 1 point) and serum CRP (> 1.0 mg/dL = 2 points) be acquired. Each of these minor criteria are weighted and a cumulative preoperative weighted score of > 6 is assumed infection for the preoperative criteria[8]. In the community setting, clinicians are limited by what their labs can test for. As a result, many PJIs at these community hospitals fall into the indeterminant range, 2-5 points, and as a result this may delay or even prevent appropriate diagnosis and treatment.
While these three diagnostic modalities have been widely utilized over the past decade with support from the musculoskeletal infection society, several other proposed diagnostic tests and criteria exist. One of these proposed criteria is to solely rely on the intra-articular enzyme alpha-defense and intra-articular CRP[13]. This notion, originally proposed by Deirmengian et al[14] has shown good sensitivity and specificity in diagnosing PJI when compared to gold standard of ICM criteria[15-18]. However, to avoid confusion, the proposed CRP-Deirmengian criteria has been excluded from this study, and only the ICM diagnostic criteria was utilized as it is the current gold standard.
In the community setting the clarity and reliability of the cell counts and neutrophil percentages on aspirate are of vital importance. Unfortunately, another major limitation of aspiration in many cases is the presence of red blood cells (RBCs) which has been suggested to influence the fidelity of the total nucleated cell count. While it has been widely implied that the presence of RBCs in joint aspirate can inflate the total nucleated cells (TNC), there has been limited research into the actual effects RBCs have on cell count. Deirmengian et al[14] released a study in 2020 that suggested samples diluted with large amounts of blood or saline should not be utilized in defining infection. This study further suggests that without fidelity of the cell counts on aspiration, many patients who end up in the “indeterminate” group when applying the ICM criteria, will have delayed diagnosis or incorrect treatments. In this study the term “grossly bloody” was defined as any fluid sample that appeared opaque and sanguinous on physical evaluation in the syringe.
The major issue is that without fidelity of synovial fluid analysis, it is impossible to meet the minimum criteria for PJI per the ICM criteria[8], which lead our cohort to investigate potential means to adjust cell counts in the setting of “bloody aspirations”. In 2008, Ghanem et al[19] published a possible correction formula to identify the “true leukocytosis” present in the prosthetic joint. This formula offers a new potential for validating the fidelity of total nucleated cell count on aspiration and since the time of publication in 2008, there has been no follow-up research applied to this proposed correction formula. Additionally, to our knowledge there has not been a definitive stance on whether this correction formula is useful in the clinical setting. The purpose of the present study is to determine the true clinical utility of the “true leukocytosis formula” through comparison with the ICM confirmed infections. By doing so, we aim to provide insight for clinicians in the community setting with limited access to various diagnostic testing modalities regarding the usefulness of this compensatory formula in the setting of a “bloody aspiration”.
A retrospective chart review was performed from January 2020 to December 2021 to evaluate patients with culture positive periprosthetic joint infection after a TKA with confirmed PJI by ICM score and culture positivity. Patient demographics including age, body mass index, gender, diabetes, hypertension, hyperlipidemia, obesity, atrial fibrillation, obstructive sleep apnea, chronic kidney disease anxiety and depression were recorded. Preoperative ICM score was calculated for each patient without alpha-defensin or intraarticular CRP, as these tests are not available at our institution[8]. Only patients with preoperative ICM scores indicating infection were included in the experimental group. We then calculated the corrected ICM score by using the cell count in conjunction with the equation from Ghanem et al[19] to identify the “true leukocytosis” present in the prosthetic joint. The proposed equation was: White blood cell (WBC)adjusted = WBCfluid – [WBCblood × (RBCfluid/RBCblood)]; where WBC stands for white blood cells and RBC stands for red blood cells. We used culture positivity as our gold standard for proven infection. We compared sensitivity, specificity, positive predictive value, negative predictive value, and area under the curve for preoperative ICM score and corrected preoperative ICM score. Culture results were also reported based on bacterial involvement.
Patients who experienced a first time PJI who underwent operative intervention with debridement, antibiotics and implant retention, or explant with placement of antibiotic spacers were included. Readmission and reinfection were not evaluated as this was deemed out of scope. Patients were excluded if recurrent infection was found, or if cultures were negative. For the purpose of this study the term “grossly bloody” refers to any synovial fluid sample that appeared opaque and sanguinous on physical evaluation in the syringe.
Descriptive statistics included reporting the numerical variables as mean, standard deviation and range, and the categorical variables as number and percent. Positive predictive value or negative predictive value were not reported due to the 100% matching between the comparison variables. All the analysis were performed with the use of SAS software, version 9.4 (SAS Institute, Cary, NC, United States).
Of the 158 cases, 81 were included in the study. Of these 81 cases, zero cases were found to have a change in the preoperative ICM score following application of the “true leukocytosis” formula proposed by Ghanem et al[19]. The results met clinical significance as 100% of patients remained at their preoperative ICM scores. There were no secondary outcomes measured for this study. The results of the patient demographics, criteria derived from the ICM criteria, results from our patients fluid aspirations, and the species of bacteria isolated from the aspirations can all be found in Tables 1, 2, 3 and 4.
| Cut off | Score1 | |
| Serum CRP | > 1 mg/dL | 2 |
| Serum D-dimer | > 860 ng/mL | 2 |
| Serum ESR | > 30 mm/hour | 1 |
| WBC (synovial) | > 3000 cells/μL | 3 |
| Alpha-defensin (synovial) | Qualitative | 3 |
| Leukocyte esterase (synovial) | Qualitative | 3 |
| Neutrophil (synovial, %) | > 80% | 2 |
| CRP (synovial) | > 6.9 mg/L | 1 |
| Characteristic | Value |
| Age (mean ± SD, range) | 68.3 ± 9.1, 52-88 |
| Gender | |
| Male | 46 (56.79) |
| Female | 35 (43.21) |
| BMI (mean ± SD, range) | 35.3 ± 8.5, 19.2-61.9 |
| 10-year survival (mean ± SD, range, %) | 65.4 ± 17.0, 0-95.9 |
| Comorbid conditions | |
| DM | 21 (25.93) |
| HLD | 34 (41.98) |
| HTN | 64 (79.01) |
| Obesity (BMI > 35) | 38 (46.91) |
| AFIB | 9 (11.11) |
| CKD | 12 (14.81) |
| Smoking | 3 (3.70) |
| Anxiety/depression | 40 (49.38) |
| Sleep apnea | 25 (30.86) |
| Average | Range | |
| RBC serum cells (× 106) | 4.02 | 2.1-5.1 |
| RBC synovial | 183761 | 4843-4063600 |
| WBC serum cells (× 103) | 10.9 | 6.3-31.7 |
| TNC synovial | 66076.5 | 117-494920 |
| Polymorphonuclear cells (%) | 87.37407407 | 74-100 |
| C-reactive protein serum | 16 | 0.6-33.9 |
| Erythrocyte sedimentation rate (mm/hour) | 60.5 | 6.8-140 |
| Bacterium isolated | Number of patients | Percent of patients |
| MRSA | 14 | 17.3 |
| Methicillin sensitive staphylococcus aureus | 21 | 25.9 |
| Coagulase negative Staphylococcu spp. | 7 | 8.6 |
| Enterobacter spp. | 4 | 4.9 |
| Pseudomonas spp. | 3 | 3.7 |
| Proteus spp. | 1 | 1.2 |
| Corynebacterium spp. | 3 | 3.7 |
| Enterococcus Faecelis | 8 | 9.9 |
| Bacteroides spp. | 1 | 1.2 |
| Group A streptococcus spp. | 5 | 6.2 |
| Peptostreptococcus spp. | 1 | 1.2 |
| Group B hemolytic streptocossu | 5 | 6.2 |
| Escherichia coli | 2 | 2.5 |
| Mycobacterium spp. | 1 | 1.2 |
| Propionibacterium acnes | 1 | 1.2 |
| Serratia spp. | 1 | 1.2 |
| Bacillus spp. | 3 | 3.7 |
TKA has seen increasing rates of utilization leading to increases in both revision TKA and PJI. Furthermore, as the ability to perform TKA becomes increasingly accessible in the community setting, many surgeons with limited resource access will be tasked with diagnosing PJI accurately. In the hospital the present study is based in, alpha defensin, synovial CRP, and leukocyte esterase are not readily available tests after an aspiration. In the setting of a bloody aspiration, without the power of these confirmatory tests, the diagnostic and therefore treatment decisions may be questioned. In this study we looked at determining whether the Ghanem et al[19] proposed correction equation for bloody aspirations of TKAs was useful in the diagnosis of PJI for TKA when a bloody tap is encountered. It was our hope that having this additional data point would be helpful in maintaining confidence in the validity of our diagnosis in a community setting where adjuvant testing is not readily available.
The patients in the study had an ICM score calculated from preoperative fluid analysis and lab values. The intra-articular WBC was then subjected to Ghanem et al[19] proposed “true” leukocytosis equation which showed that zero patients had a change to their ICM score following application of the “true” leukocytosis equation. Unfortunately, our team has interpreted this to mean that this proposed equation is not a useful adjuvant in routinely diagnosing PJI. While our cohort was relatively small in this study, we believe the equation’s proposed formula would likely require increasingly large amounts of RBCs (> 5000000/mL) in joint fluid aspirate to create a substantial change to the intra-articular WBC count. This, however, does appear to coincide with Deirmengian et al[14] study from 2020 that suggested nucleated cell counts began to lose their fidelity in samples with greater than 1000000 RBCs/mL. In this context, perhaps aspirations which are frankly bloody and present with greater than 1000000 RBC would benefit from the correction.
The results of this study suggest that the previously hypothesized effects of RBC in aspirate on cell count may not be as clinically significant in samples with < 1000000 RBCs/mL. Given that there was minimal change in TNC before and after correction using the proposed equation, in our opinion, reflects that more confidence can be placed in TNC following aspirations even if they are grossly bloody. At this time, it appears that this equation is not as valuable as originally thought for routine aspirations with moderate amounts of RBCs. Given the increasing availability of newer diagnostic testing, such as intra-articular alpha-defensin, the absolute necessity of traditional fluid analysis may become less favorable when compared to these newer tests. If that is the case, this may be an area of study that while interesting may yield diminishing returns. However, until these newer tests are available in all settings, aspirate fluid analysis and utilization of the ICM score will continue to be the gold standard.
We conclude that there appears to be little to no effect on ICM criteria scores when the proposed correction formula applies. When we compared sensitivity and specificity of corrected score to the gold standard of culture positivity, there was no change in results compared to the uncorrected scores[9]. This could point to the fact that RBCs in aspirations present little to no effect on the cell count, contrary to previous thoughts[20]. For this reason, we propose that no correction to cell count needs to be done prior to diagnosis of PJI for TKA in which the sample is not grossly bloody.
| 1. | Kugler CM, Goossen K, Rombey T, De Santis KK, Mathes T, Breuing J, Hess S, Burchard R, Pieper D. Hospital volume-outcome relationship in total knee arthroplasty: a systematic review and dose-response meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2022;30:2862-2877. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 19] [Cited by in RCA: 17] [Article Influence: 4.3] [Reference Citation Analysis (0)] |
| 2. | Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-785. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2079] [Cited by in RCA: 3310] [Article Influence: 174.2] [Reference Citation Analysis (0)] |
| 3. | Livshetz I, Sussman BH, Papas V, Mohamed NS, Salem HS, Delanois RE, Mont MA, Scuderi GR. Analyzing the Burden of Revision Total Knee Arthroplasty in the United States between 2009 and 2016. J Knee Surg. 2023;36:121-131. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 10] [Article Influence: 3.3] [Reference Citation Analysis (0)] |
| 4. | Premkumar A, Kolin DA, Farley KX, Wilson JM, McLawhorn AS, Cross MB, Sculco PK. Projected Economic Burden of Periprosthetic Joint Infection of the Hip and Knee in the United States. J Arthroplasty. 2021;36:1484-1489.e3. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 107] [Cited by in RCA: 508] [Article Influence: 101.6] [Reference Citation Analysis (1)] |
| 5. | Singh JA, Yu S, Chen L, Cleveland JD. Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample. J Rheumatol. 2019;46:1134-1140. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 300] [Cited by in RCA: 814] [Article Influence: 116.3] [Reference Citation Analysis (0)] |
| 6. | Sabah SA, Alvand A, Price AJ. Revision knee replacement for prosthetic joint infection: Epidemiology, clinical outcomes and health-economic considerations. Knee. 2021;28:417-421. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 12] [Cited by in RCA: 55] [Article Influence: 11.0] [Reference Citation Analysis (0)] |
| 7. | Gademan MGJ, Van Steenbergen LN, Cannegieter SC, Nelissen RGHH, Marang-Van De Mheen PJ. Population-based 10-year cumulative revision risks after hip and knee arthroplasty for osteoarthritis to inform patients in clinical practice: a competing risk analysis from the Dutch Arthroplasty Register. Acta Orthop. 2021;92:280-284. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 5] [Cited by in RCA: 26] [Article Influence: 5.2] [Reference Citation Analysis (0)] |
| 8. | Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF, Shohat N. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty. 2018;33:1309-1314.e2. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 885] [Cited by in RCA: 1548] [Article Influence: 193.5] [Reference Citation Analysis (0)] |
| 9. | Bauer TW, Parvizi J, Kobayashi N, Krebs V. Diagnosis of periprosthetic infection. J Bone Joint Surg Am. 2006;88:869-882. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 127] [Cited by in RCA: 163] [Article Influence: 8.2] [Reference Citation Analysis (0)] |
| 10. | McNally M, Sousa R, Wouthuyzen-Bakker M, Chen AF, Soriano A, Vogely HC, Clauss M, Higuera CA, Trebše R. The EBJIS definition of periprosthetic joint infection. Bone Joint J. 2021;103-B:18-25. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 101] [Cited by in RCA: 509] [Article Influence: 101.8] [Reference Citation Analysis (0)] |
| 11. | Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992-2994. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1212] [Cited by in RCA: 1505] [Article Influence: 100.3] [Reference Citation Analysis (1)] |
| 12. | Parvizi J, Ghanem E, Menashe S, Barrack RL, Bauer TW. Periprosthetic infection: what are the diagnostic challenges? J Bone Joint Surg Am. 2006;88 Suppl 4:138-147. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 86] [Cited by in RCA: 129] [Article Influence: 6.5] [Reference Citation Analysis (0)] |
| 13. | Johansen JG, Lilleas FG, Nordshus T. Arthrography of the knee joint with amipaque. Acta Radiol Diagn (Stockh). 1977;18:523-528. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 5] [Cited by in RCA: 5] [Article Influence: 0.1] [Reference Citation Analysis (0)] |
| 14. | Deirmengian C, Feeley S, Kazarian GS, Kardos K. Synovial Fluid Aspirates Diluted with Saline or Blood Reduce the Sensitivity of Traditional and Contemporary Synovial Fluid Biomarkers. Clin Orthop Relat Res. 2020;478:1805-1813. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 15] [Cited by in RCA: 31] [Article Influence: 5.2] [Reference Citation Analysis (0)] |
| 15. | Tetreault MW, Wetters NG, Moric M, Gross CE, Della Valle CJ. Is synovial C-reactive protein a useful marker for periprosthetic joint infection? Clin Orthop Relat Res. 2014;472:3997-4003. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 66] [Cited by in RCA: 86] [Article Influence: 7.2] [Reference Citation Analysis (0)] |
| 16. | Uvodich ME, Dugdale EM, Osmon DR, Pagnano MW, Berry DJ, Abdel MP. The effectiveness of laboratory tests to predict early postoperative periprosthetic infection after total knee arthroplasty. Bone Joint J. 2021;103-B:177-184. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4] [Cited by in RCA: 20] [Article Influence: 4.0] [Reference Citation Analysis (0)] |
| 17. | Kleeman-Forsthuber LT, Dennis DA, Brady AC, Pollet AK, Johnson RM, Jennings JM. Alpha-Defensin Is Not Superior to Traditional Diagnostic Methods for Detection of Periprosthetic Joint Infection in Total Hip Arthroplasty and Total Knee Arthroplasty Patients. J Arthroplasty. 2021;36:2144-2149. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 3] [Cited by in RCA: 12] [Article Influence: 2.4] [Reference Citation Analysis (0)] |
| 18. | Kleeman-Forsthuber LT, Johnson RM, Brady AC, Pollet AK, Dennis DA, Jennings JM. Alpha-Defensin Offers Limited Utility in Routine Workup of Periprosthetic Joint Infection. J Arthroplasty. 2021;36:1746-1752. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 4] [Cited by in RCA: 17] [Article Influence: 3.4] [Reference Citation Analysis (0)] |
| 19. | Ghanem E, Houssock C, Pulido L, Han S, Jaberi FM, Parvizi J. Determining "true" leukocytosis in bloody joint aspiration. J Arthroplasty. 2008;23:182-187. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 40] [Cited by in RCA: 32] [Article Influence: 1.8] [Reference Citation Analysis (0)] |
| 20. | Ottink KD, Strahm C, Muller-Kobold A, Sendi P, Wouthuyzen-Bakker M. Factors to Consider When Assessing the Diagnostic Accuracy of Synovial Leukocyte Count in Periprosthetic Joint Infection. J Bone Jt Infect. 2019;4:167-173. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 23] [Cited by in RCA: 37] [Article Influence: 5.3] [Reference Citation Analysis (0)] |
